Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Osisko Development | ODV | Apr 25, 2024 | 2.06 | +0.49 |
Osisko Gold Royalties | OR | Apr 25, 2024 | 15.94 | +1.27 |
Ostin Technology Group | OST | Apr 25, 2024 | 0.41 | -10.91 |
Otis Worldwide | OTIS | Apr 25, 2024 | 93.02 | -0.37 |
Otter Tail | OTTR | Apr 25, 2024 | 85.57 | -0.15 |
Ouster | OUST | Apr 25, 2024 | 7.48 | +0.67 |
Outfront Media | OUT | Apr 25, 2024 | 15.34 | -0.71 |
Outlook Therapeutics | OTLK | Apr 25, 2024 | 8.19 | -0.12 |
Outset Medical | OM | Apr 25, 2024 | 2.38 | -6.67 |
Overseas Shipholding A | OSG | Apr 25, 2024 | 6.06 | -0.33 |
Ovid Therapeutics | OVID | Apr 25, 2024 | 2.99 | -5.08 |
Ovintiv | OVV | Apr 25, 2024 | 53.14 | +0.45 |
Owens & Minor | OMI | Apr 25, 2024 | 24.12 | -2.51 |
Owens Corning | OC | Apr 25, 2024 | 165.04 | -0.11 |
Owlet A | OWLT | Apr 25, 2024 | 3.98 | 0.00 |
Oxbridge Re | OXBR | Apr 25, 2024 | 1.06 | -3.53 |
Oxford Industries | OXM | Apr 25, 2024 | 105.75 | -1.40 |
Oxford Lane Capital | OXLC | Apr 25, 2024 | 4.96 | -0.20 |
Oxford Lane Capital 2024 Pref | OXLCM | Apr 25, 2024 | 24.95 | -0.08 |
Oxford Lane Capital 2027 Pref | OXLCP | Apr 25, 2024 | 23.48 | +0.30 |
Oxford Square Capital | OXSQ | Apr 25, 2024 | 3.19 | -0.62 |
P.A.M. Transportation Services | PTSI | Apr 25, 2024 | 17.15 | +17.95 |
P10 | PX | Apr 25, 2024 | 7.40 | -2.50 |
P3 Health Partners A | PIII | Apr 25, 2024 | 0.48 | -4.08 |
PACCAR | PCAR | Apr 25, 2024 | 112.62 | -0.98 |
Pacific Biosciences of California | PACB | Apr 25, 2024 | 1.38 | +1.47 |
Pacific ETF FTSE Vanguard | VPL | Apr 25, 2024 | 72.02 | -0.94 |
Pacific Ex-Japan MSCI Ishares | EPP | Apr 25, 2024 | 41.81 | -0.12 |
Pacific Gas & Electric | PCG | Apr 25, 2024 | 17.07 | +0.41 |
Pacific Gas & Electric Pref A | PCG-A | Apr 25, 2024 | 23.59 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.